Ray Barlow, CEO of e-Therapeutics, talks to Scrip about network-driven discovery and its use by today's innovative pharma sector. Barlow talks about working backwards to solve a problem, starting with the end target in mind and then thinking about how to apply new technologies to reach the bullseye. e-therapeutics' technology works by combining biological expertise and a powerful computer-based platform to create and analyze network models of disease to identify likely proteins that could be disrupted to treat a disease. It uses mathematical and data analysis techniques to augment and interrogate the vast amount of biological information currently available in both public and private databases. With its technology, the company aims to shorten discovery times and reduce drug development costs.
Get the latest news as it happens.